MARSHALL WACE, LLP - NXSTAGE MEDICAL INC ownership

NXSTAGE MEDICAL INC's ticker is NXTM and the CUSIP is 67072V103. A total of 175 filers reported holding NXSTAGE MEDICAL INC in Q3 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of NXSTAGE MEDICAL INC
ValueSharesWeighting
Q4 2018$39,875,000
-37.8%
1,393,302
-39.3%
0.41%
+49.1%
Q3 2018$64,066,000
+162.8%
2,297,084
+162.9%
0.27%
-25.2%
Q2 2018$24,381,000
-3.4%
873,878
-13.9%
0.36%
-65.1%
Q1 2018$25,232,000
+278.4%
1,014,975
+268.8%
1.05%
+273.6%
Q4 2017$6,668,000
+261.2%
275,189
+317.3%
0.28%
+225.6%
Q3 2017$1,846,000
-69.1%
65,940
-71.1%
0.09%
+120.5%
Q4 2016$5,976,000
+34.1%
228,002
+11.0%
0.04%
+5.4%
Q2 2016$4,455,000
+660.2%
205,492
+425.7%
0.04%
+516.7%
Q1 2016$586,00039,0860.01%
Other shareholders
NXSTAGE MEDICAL INC shareholders Q3 2017
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 2,721,906$73,029,00011.38%
DAFNA Capital Management LLC 216,119$5,798,0004.90%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,744,151$100,456,0003.87%
KOPP INVESTMENT ADVISORS LLC 117,779$3,160,0003.09%
Perceptive Advisors 1,818,189$48,782,0002.78%
Pennant Capital Management, LLC 1,927,408$51,712,0002.45%
GILDER GAGNON HOWE & CO LLC 4,955,630$132,960,0002.24%
PURA VIDA INVESTMENTS, LLC 275,000$7,378,0002.18%
Portolan Capital Management 545,032$14,623,0001.90%
Tamarack Advisers, LP 110,000$2,951,0001.84%
View complete list of NXSTAGE MEDICAL INC shareholders